Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Modal CAR T cells: A synthetic cytokine circuit to overcome TGFβ-mediated immunosuppression in AML

Fuguo Liu, Xingyu Deng, Veronica Hui, Maily Nguyen, Wenxin Xu, Mubin Tarannum, Andreia Maia, Shaobo Yang, Remy Dulery, Stephanie Sendker, Alaa Ali, John Koreth, Jose Cancelas, Jianzhu Chen, Robert Soiffer, Catherine Wu, Jerome Ritz, Toni Choueiri, Rizwan Romee

Blood (2025) 146 (Supplement 1): 4096.

https://doi.org/10.1182/blood-2025-4096

Published: 2025

Journal Articles

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Blood (2025) 146 (Supplement 1): 6065.

https://doi.org/10.1182/blood-2025-6065

Published: 2025

Journal Articles

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Ansh Mehta, Haesook Kim, Arcita Pramudita, Deborah Liney, Remy Dulery, Vincent Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Sarah Nikiforow, Prashant Nageshwar, Catherine Wu, Jerome Ritz, Rizwan Romee, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2025-4227

Published: 2025

Journal Articles

Unannotated open reading frames expand the antigen repertoire in T cell acute lymphoblastic leukemia

Gbolahan Bamgbose, Caroline Wiggers, Burak Yuzuguldu, Jenn Abelin, Steven Carr, Catherine Wu, Jens Lohr, Birgit Knoechel

Blood (2025) 146 (Supplement 1): 5147.

https://doi.org/10.1182/blood-2025-5147

Published: 2025

Journal Articles

Systematic molecular profiling to identify determinants of response to ibrutinib

Blood (2025) 146 (Supplement 1): 3881.

https://doi.org/10.1182/blood-2025-3881

Published: 2025

Journal Articles

Acquisition of CLL-like epigenetic and transcriptomic states in low-count MBL

Anja Rathgeber, Stacey Fernandes, Adi Nagler, Shuqiang Li, David Dorfman, Lars Bullinger, Matthew S Davids, Jennifer Brown, Kenneth Livak, Leif Ludwig, Catherine Wu, Livius Penter

Blood (2025) 146 (Supplement 1): 3876.

https://doi.org/10.1182/blood-2025-3876

Published: 2025

Journal Articles

Development of a novel multiomic sequencing approach to characterize infused donor memory-like NK cells in an immune compatible environment

Roman Shapiro, Grace Birch, Chen Weng, Jonas Gudera, Michael Poeschla, Matthew Booker, Michael Tolstorukov, Michal Sheffer, Remy Dulery, Sarah Nikiforow, John Koreth, Catherine Wu, Robert Soiffer, Jerome Ritz, Vijay Sankaran, Rizwan Romee

Blood (2025) 146 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2025-2352

Published: 2025

Journal Articles

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Blood (2025) 146 (Supplement 1): 1525.

https://doi.org/10.1182/blood-2025-1525

Published: 2025

Journal Articles

Distinct archetypes of clonal dynamics underlie response and resistance to diverse CLL therapies

Blood (2025) 146 (Supplement 1): 245.

https://doi.org/10.1182/blood-2025-245

Published: 2025

Journal Articles

Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy

Blood (2025) 146 (Supplement 1): 243.

https://doi.org/10.1182/blood-2025-243

Published: 2025

Journal Articles

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

Nicoletta Cieri, Yiren Shao, Luis Correa-Medero, Julia Keating, Meilun He, Yung-Tsi Bolon, Griffin Lawrence, Jerome Ritz, Robert Soiffer, Jenn Abelin, Donna Neuberg, Stephen Spellman, Catherine Wu

Blood (2025) 146 (Supplement 1): 4249.

https://doi.org/10.1182/blood-2025-4249

Published: 2025

Journal Articles

LIME: A first-in-class of live bacterial immune engagers for cancer immunotherapy

Blood (2025) 146 (Supplement 1): 264.

https://doi.org/10.1182/blood-2025-264

Published: 2025

Journal Articles

Reprogramming CAR-NK cells with IL-7/IL-7Rα to amplify STAT1 signaling and activate bystander T cells for enhanced immunotherapy

Blood (2025) 146 (Supplement 1): 4129.

https://doi.org/10.1182/blood-2025-4129

Published: 2025

Journal Articles

Overcoming CAR T cell resistance in NPM1c and KMT2Ar AML through menin pathway inhibition

Sara Piccinelli, Wallace Bourgeois, Andreia Maia, Eden Bobilev, Fuguo Liu, Xingyu Deng, Han Dong, Robert Soiffer, Catherine Wu, Jerome Ritz, Daniel Deangelo, Andrew Lane, Roman Shapiro, Jianzhu Chen, John Koreth, Rizwan Romee

Blood (2025) 146 (Supplement 1): 2319.

https://doi.org/10.1182/blood-2025-2319

Published: 2025

Journal Articles

Nodal progression in CLL: Real-world predictors of richter transformation and identification of a distinct high-risk NP-CLL subgroup

Nathalie Javidi-Sharifi, Sobana Balasubramanian, Hannah Lee, Paulina Predko, Svitlana Tyekucheva, Amber Mitchell, Stacey Fernandes, Roberta Santos Azevedo, Erin Parry, Catherine Wu, Matthew S Davids, Jennifer Brown

Blood (2025) 146 (Supplement 1): 5682.

https://doi.org/10.1182/blood-2025-5682

Published: 2025

Journal Articles

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Remy Dulery, Sandra Lee, Sarah Nikiforow, Carol Reynolds, Heather Garrity, Karl Stasko, Andrew Mason, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Vincent Ho, Catherine Wu, Rizwan Romee, Jerome Ritz, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4260.

https://doi.org/10.1182/blood-2025-4260

Published: 2025

Journal Articles

Mechanisms of immune escape and altered tissue homing in leukemia cutis

Livius Penter, Alexandria Maurer, Nicoletta Cieri, Wesley Lu, Haoxiang Lyu, Shuqiang Li, Kenneth Livak, Lars Bullinger, Jerome Ritz, Pavan Bachireddy, Matthew S Davids, Jacqueline Garcia, Robert Soiffer, Catherine Wu

Blood (2025) 146 (Supplement 1): 2483.

https://doi.org/10.1182/blood-2025-2483

Published: 2025

Journal Articles

Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRα, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants

Blood (2010) 115 (21): 4206–4216.

https://doi.org/10.1182/blood-2009-11-251751

Published: 2010

Includes: Supplemental data

Journal Articles

Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.

Paul M. Armistead, MD, PhD, Mehrdad Mohseni, MD, Roslyn Gerwin, Masood Iravani, MD, Bahram Chardouli, Sharbano Rhostami, Ardeshir Ghavamzadeh, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Catherine Wu, MD

Blood (2007) 110 (11): 2996.

https://doi.org/10.1182/blood.V110.11.2996.2996

Published: 2007

Journal Articles

Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism.

Paul Armistead, MD, PhD, Mehrdad Mohseni, MD, Roslyn Gerwin, Wandi Zhang, Masoud Iravani, MD, Ardeshir Ghavamzadeh, MD, Jerome Ritz, MD, Catherine Wu, MD

Blood (2005) 106 (11): 5233.

https://doi.org/10.1182/blood.V106.11.5233.5233

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Modal CAR T cells: A synthetic cytokine circuit to overcome TGFβ-mediated immunosuppression in AML

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Unannotated open reading frames expand the antigen repertoire in T cell acute lymphoblastic leukemia

Systematic molecular profiling to identify determinants of response to ibrutinib

Acquisition of CLL-like epigenetic and transcriptomic states in low-count MBL

Development of a novel multiomic sequencing approach to characterize infused donor memory-like NK cells in an immune compatible environment

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Distinct archetypes of clonal dynamics underlie response and resistance to diverse CLL therapies

Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

LIME: A first-in-class of live bacterial immune engagers for cancer immunotherapy

Reprogramming CAR-NK cells with IL-7/IL-7Rα to amplify STAT1 signaling and activate bystander T cells for enhanced immunotherapy

Overcoming CAR T cell resistance in NPM1c and KMT2Ar AML through menin pathway inhibition

Nodal progression in CLL: Real-world predictors of richter transformation and identification of a distinct high-risk NP-CLL subgroup

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Mechanisms of immune escape and altered tissue homing in leukemia cutis

Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRα, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants

Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.

Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only